Arkolith/Insider Trading/CUE/Form 4

Sarraf Pasha

DirectorCue Biopharma, Inc. (CUE) · full profile →Form 4 · filed Jan 2, 2026
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 30, 2025Buy(P)77K$0.30$23K324K
Dec 30, 2025Buy(P)87K$0.32$28K168K
Dec 30, 2025Buy(P)77K$0.30$23K81K
Dec 30, 2025Buy(P)4K$0.31$1K4K
Dec 30, 2025Buy(P)78K$0.31$24K246K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-000900) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Cue Biopharma, Inc.

Build

Ask your agent about CUE insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001193125-26-000900"
Ask your agent
Use Arkolith to summarize insider buying and selling at Cue Biopharma, Inc.
over the last 90 days and cite the filings.